William Harding of Morningstar Investment Management, head of alternatives research Nadia Papagiannis, and ETF analyst Tim Strauts outline smart diversification strategies in this 50-minute roundtable discussion.
The burdens of a possible Cadbury acquisition and Kraft's recent decision not to raise its dividend (a first since its spin-off) should give dividend investors pause.
Morningstar's Bill Bergman comments on Berkshire's current penchant for capital-intensive businesses and the outlook for its operating companies.
Facing dwindling drug pipelines, plenty of big pharma firms may end up jumping into the bidding for Genzyme, according to Morningstar's Karen Andersen.
©2012 Morningstar Advisor. All right reserved.